Cervical cancer (over)screening in Belgium and Switzerland: trends and social inequalities.

European Journal of Public Health
Vincent De PrezPiet Bracke

Abstract

Cervical cancer screening (CCS) by means of Pap smears has led to a decrease in cervical cancer incidence and mortality. In the absence of organized programmes, CCS is opportunistic in Belgium and Switzerland. This might result in a high level of CCS overuse, as screening practices do not conform to the recommended 3-yearly screening interval and the target age-ranges (Belgium: 25-64, Switzerland: 20-70). This study aimed to assess trends in CCS uptake and overuse in Belgium and Switzerland and their social determinants, in the light of reimbursement initiatives, which were implemented in both countries. Data from five waves of the Belgian Health Interview Survey (1997-2013) (N=11 141) and Swiss Health Interview Survey (1992-2012) (N=32 696) were used. We performed Poisson regressions to estimate adjusted prevalence ratios (APR), controlled for socio-economic and socio-demographic characteristics and health status. CCS overuse was operationalized as screening more than once every 3 years and screening above recommended age-range. CCS uptake remained relatively stable over time, with a mean coverage of 70.9% in Belgium and 73.1% in Switzerland. Educational and income gradients were found in both countries. Concerning CCS overuse...Continue Reading

References

Aug 1, 1997·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·M ArbynH Van Oyen
Nov 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Arbyn, H Van Oyen
Nov 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LeviC la Vecchia
May 18, 2001·Health Promotion International·S C Ratzan
Jan 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A B Miller
Apr 2, 2004·Cytopathology : Official Journal of the British Society for Clinical Cytology·A PlacidiM Arbyn
Jan 20, 2005·Gynäkologisch-geburtshilfliche Rundschau·UNKNOWN Arbeitsgruppe "Guideline Zervixabstrich"
Jan 7, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marc ArbynChristophe Depuydt
Aug 22, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marc ArbynAhti Anttila
Aug 22, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marc ArbynBengt Andrae
Feb 24, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ArbynL von Karsa
Sep 6, 2012·Swiss Medical Weekly·Patrick PetignatPierre Vassilakos
Nov 20, 2012·American Journal of Obstetrics and Gynecology·Jillian T HendersonGeorge F Sawaya
Jul 3, 2013·European Journal of Public Health·Pilar Carrasco-GarridoRodrigo Jimenez-Garcıa
Mar 19, 2014·Journal of Lower Genital Tract Disease·Lauren VerrilliConstance Mao
Jul 1, 2014·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Pamela BarbadoroEmilia Prospero
Mar 5, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Clare TantonPam Sonnenberg
Mar 27, 2015·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Helena Van Kerrebroeck, Amin Makar
Mar 31, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K Miriam ElfströmJoakim Dillner
May 1, 2015·Annals of Internal Medicine·George F SawayaUNKNOWN Clinical Guidelines Committee of American College of Physicians
Jan 9, 2017·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Lucia Guerra-ReyesKatie A Siek
Oct 25, 2017·International Journal of Public Health·Barbara Willems, Piet Bracke
Aug 28, 2018·Preventive Medicine·Julia M AlberKaren Glanz

❮ Previous
Next ❯

Citations

Oct 9, 2020·BMC Public Health·Vladimir JolidonClaudine Burton-Jeangros
Jul 8, 2020·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Marie-Caroline de PelsemaekerMieke Rosalie Van Bockstal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephron. Clinical Practice
Petr BubenicekVladimir Teplan
Pediatrics International : Official Journal of the Japan Pediatric Society
Yasushi IshidaKeizo Horibe
Pediatrics International : Official Journal of the Japan Pediatric Society
Naoko IwaiMegumi Oda
Risk Analysis : an Official Publication of the Society for Risk Analysis
Carola Braun
© 2021 Meta ULC. All rights reserved